HUTCHMED (China) (HCM) Receivables (2014 - 2025)
HUTCHMED (China)'s (HCM) quarterly Receivables came in at $16.3 million in Q4 2025, down 41.6% year-on-year from $27.9 million in Q4 2024, and down 90.33% on a QoQ basis from $168.5 million in Q2 2025.
HUTCHMED (China) (HCM) Receivables (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 12 years of Receivables data on file, last reported at $16.3 million in Q4 2025.
- On a quarterly basis, Receivables fell 41.6% year-over-year to $16.3 million in Q4 2025; TTM through Dec 2025 was $16.3 million, a 41.6% decrease from a year earlier, with the FY2025 full-year figure at $16.3 million, down 18.24% from the prior year.
- Receivables for Q4 2025 stood at $16.3 million, down from $168.5 million in the prior quarter.
- Over the last five years, Receivables for HCM reached as high as $15.0 billion in Q4 2023 and fell as low as $10.7 million in Q4 2021.
- Historically, Receivables has averaged $1.4 billion across 5 years, with a median of $90.1 million in 2021.
- Across the five-year window, Receivables surged 119327.04% in 2023 and sank 99.81% in 2024, its largest moves.
- Year by year, Receivables stood at $10.7 million in 2021, then climbed by 16.75% to $12.5 million in 2022, then jumped by 119327.04% to $15.0 billion in 2023, then sank by 99.81% to $27.9 million in 2024, then tumbled by 41.6% to $16.3 million in 2025.
- Per Business Quant data, the three most recent Receivables figures were $16.3 million in Q4 2025, $168.5 million in Q2 2025, and $27.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 16.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.30 Mn |
| Jun 30, 2025 | 168.47 Mn |
| Dec 31, 2024 | 27.91 Mn |
| Jun 30, 2024 | 171.63 Mn |
| Dec 31, 2023 | 14.96 Bn |
| Jun 30, 2023 | 158.48 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Jun 30, 2022 | 150.11 Mn |
| Dec 31, 2021 | 10.73 Mn |
| Jun 30, 2021 | 90.07 Mn |
| Mar 31, 2021 | 53.13 Mn |
| Dec 31, 2020 | 18.33 Mn |
| Jun 30, 2020 | 62.12 Mn |
| Dec 31, 2019 | 13.04 Mn |
| Sep 30, 2019 | 40.33 Mn |
| Jun 30, 2019 | 42.76 Mn |
| Mar 31, 2019 | 42.27 Mn |
| Dec 31, 2018 | 2.41 Mn |
| Jun 30, 2018 | 58.73 Mn |
| Dec 31, 2017 | 49.96 Mn |